Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Carolyn J. Friel"'
Autor:
Carolyn J. Friel
Publikováno v:
Medicinal Chemistry of Drugs Affecting the Nervous System
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a503f943f5f71e488561db53201c4aa
https://doi.org/10.2174/9789811454073120020009
https://doi.org/10.2174/9789811454073120020009
Autor:
Carolyn J. Friel, Chase Smith
Publikováno v:
Currents in pharmacy teachinglearning. 13(8)
Background and purpose Students in the doctor of pharmacy curriculum have varied backgrounds in their chemical training and also their ability to make mental conversions from two-dimensional chemical representations, on lecture slides or textbook ima
Publikováno v:
Journal of Consumer Health on the Internet. 19:149-160
The purpose of this community outreach project was to improve health information literacy skills and lead poisoning knowledge in underserved early adolescents. An interactive curriculum focusing on one website (MedlinePlus) and one health issue (lead
Publikováno v:
Perioperative Nursing Clinics. 5:203-214
Publikováno v:
Journal of Medicinal Chemistry. 48:4300-4311
As part of our ongoing program to develop probes for the hormone binding domain of the estrogen receptor-alpha (ERalpha), we prepared and evaluated a series of 17alpha,Z-(4-substituted-phenyl)vinyl estradiol derivatives. The results indicated that th
Autor:
James A. Mobley, James O. L'Esperance, Mengchu Wu, Carolyn J. Friel, Robert H. Hanson, Shuk-Mei Ho
Publikováno v:
Molecular Cancer Therapeutics. 3:587-596
Prostate cancer remains the number one cause of noncutaneous cancer, with 220,900 new cases predicted for the year 2003 alone. Of the more promising classes of compounds studied thus far for the treatment of prostate cancer, estrogens of various type
Autor:
James A, Mobley, James O, L'Esperance, Mengchu, Wu, Carolyn J, Friel, Robert H, Hanson, Shuk-Mei, Ho
Publikováno v:
Molecular cancer therapeutics. 3(5)
Prostate cancer remains the number one cause of noncutaneous cancer, with 220,900 new cases predicted for the year 2003 alone. Of the more promising classes of compounds studied thus far for the treatment of prostate cancer, estrogens of various type
Autor:
Eugene R. DeSombre, Robert Dilis, Carolyn J. Friel, and Alun Hughes, Choon Young Lee, Robert N. Hanson
Publikováno v:
Journal of medicinal chemistry. 46(14)
As part of our program to develop probes for the hormone binding domain of the estrogen receptor alpha (ERalpha), we prepared a series of 4-para-substituted phenylvinyl estradiol derivatives using a combination of solution and solid-phase Pd(0)-catal